Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.02.2026 UNCU.LN IE00BD6GCF16 816,921.00 USD 37,076,722.18 45.386  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.02.2026 FXGB LN IE00BD5HBR05 37,992.00 GBP 756,458.36 26.887  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.02.2026 UINC IE00BZBW4Z27 9,869,448.00 USD 376,182,413.78 38.116  ...

WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating cardiovascular diseases, today announced that the European Medicines Agency (EMA) has granted Orphan Drug designation to Affinia for AFTX-201. AFTX-201 is a potential first-in-class and best-in-class investigational genetic medicine for the treatment of BAG3-associated di...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.02.2026 FTFX IE00BD5HBQ97 63,402.00 USD 1,671,297.59 26.360  ...

CAESAREA, Israel--(BUSINESS WIRE)--Delta Galil Industries, Ltd. today reported financial results for the fourth quarter and year ended December 31, 2025....

MILWAUKEE--(BUSINESS WIRE)--Zywave launches four insurance-specialized AI agents to streamline workflows and help brokers drive faster, smarter growth....

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that the Company will host a conference call and webcast to discuss its fourth quarter and full year 2025 financial results and business updates on Wednesday, March 4, 2026, at 4:30 pm ET. To access the conference call, please dial (888) 596-4144 (U.S.) or (646) 968-2525 (international) and enter the passco...

HOUSTON--(BUSINESS WIRE)--Starlab Space LLC, the commercial space station developer expanding access to low Earth orbit research, today announced a partnership with Helogen Corporation, the automation platform industrializing orbit by enabling scalable, regulatory-grade manufacturing and autonomous biological operations in space. Together, the companies will expand how life sciences research is conducted in microgravity, moving from isolated experiments toward persistent, scalable discovery in...

MILPITAS, Calif.--(BUSINESS WIRE)--SolarEdge Technologies, Inc. (Nasdaq: SEDG), a global leader in smart energy technology, today announced its financial results for the fourth quarter and year ended December 31, 2025. “Our fourth quarter results delivered 70% year-over-year revenue growth, marking our fourth consecutive quarter of year-over-year revenue growth and fifth consecutive quarter of margin expansion,” said Shuki Nir, CEO of SolarEdge. “In 2025 we restored discipline, generated strong...